September 26, 2016 12:28 AM ET

Biotechnology

Company Overview of Genzyme General

Company Overview

Genzyme Corporation operates as a biotechnology company. It operates through five segments: Renal, Therapeutics, Transplant, Biosurgery, and Diagnostics/Genetics. The Renal segment engages in developing, manufacturing, and distributing products that treat patients suffering from renal diseases, including chronic renal failure. Its products include Renagel, which is a non-absorbed, calcium-free, and metal-free phosphate binder indicated for the control of serum phosphorus in patients with chronic kidney disease on hemodialysis; and Hectorol, which is a line of vitamin D2 pro-hormone products. The Therapeutics segment engages in development, manufacture, and distribution of therapeutic product...

One Kendall Square

Cambridge, MA 02139

United States

Founded in 1981

Phone:

617-252-7500

Fax:

781-893-9535

Key Executives for Genzyme General

Genzyme General does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Genzyme General, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.